Results 91 to 100 of about 499 (149)

Effective long-term prophylaxis with lanadelumab in adolescents with hereditary angioedema: EMPOWER/ENABLE. [PDF]

Pediatr Allergy Immunol
Tachdjian R, Banerji A, Busse PJ, Agmon-Levin N, Anderson J, Cancian M, Spadaro G, Enciu C, Estepan DN, Khutoryansky N, Jain S, Recke A.   +11 more
europepmc   +1 more source

Reductions in medical visits and hospitalizations following berotralstat initiation in patients with hereditary angioedema in the United States. [PDF]

J Manag Care Spec Pharm
Christiansen SC, Lopez-Gonzalez L, MacKnight SD, Laliberté F, Spencer C, Boudreau J, Nestler-Parr S, Johnston DT, Gillard P, Zuraw BL.   +9 more
europepmc   +1 more source

Content validation of the Angioedema Quality of Life Questionnaire (AE-QoL) in a population of adult and adolescent patients with hereditary angioedema (HAE). [PDF]

J Patient Rep Outcomes
Broderick L, Foster A, Waldman LT, Jacobs KD, Bordone L, Yarlas A.   +5 more
europepmc   +1 more source

[Hereditary angioedema].

Lijecnicki vjesnik, 1984
N, Cikes, N, Pasini
openaire   +1 more source

Analysis of prodromal symptoms and need for short-term prophylaxis in angioedema patients under long-term prophylaxis. [PDF]

Orphanet J Rare Dis
Lochbaum R, Hoffmann TK, Greve J, Hahn J.   +3 more
europepmc   +1 more source

Centralized care model for hereditary angioedema overcomes geographical barriers. [PDF]

Front Immunol
Holmes A, Srinivasan C, Borle J, Blain H, Ritchie B, Adatia A.   +5 more
europepmc   +1 more source

Lanadelumab in a kidney transplant patient with hereditary angioedema due to C1-inhibitor deficiency and high cardiovascular risk - a case report. [PDF]

Front Immunol
Gidaro A, La Cava L, Donadoni M, Popescu Janu V, Cogliati C, Brucato AL, Zanichelli A, Cancian M, Bizzi E.   +8 more
europepmc   +1 more source

Network Meta-Analysis of Pharmacological Therapies for Long-Term Prophylactic Treatment of Patients with Hereditary Angioedema. [PDF]

Drugs R D
Walsh S, Bartlett M, Salvo-Halloran EM, Sears J, Li Y, Kelly M, Gavata-Steiger S, Nenci C, Jacobs I, Pragst I, Ray N, Samjoo IA.   +11 more
europepmc   +1 more source

Population Pharmacokinetic/Pharmacodynamic and Exposure-Response Modeling of Garadacimab in Healthy Volunteers and Patients With Hereditary Angioedema. [PDF]

CPT Pharmacometrics Syst Pharmacol
Garcia R, Cheng S, Glassman F, Sharma A, De Miguel-Lillo B, Wiens M, Johnston C, Lawo JP, Pragst I, French J, Polhamus D, Nandy P.   +11 more
europepmc   +1 more source

Hereditary angioedema due to C1-inhibitor deficiency: current therapeutic approaches. [PDF]

Curr Opin Allergy Clin Immunol
Costanzo G, Sambugaro G, Firinu D.
europepmc   +1 more source